Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026)
Nuwellis' (NUWE) quarterly Income from Continuing Operations came in at 4541000.0 in Q1 2026, down 50.66% YoY from 9204151.98 in Q1 2025, and down 87.49% on a QoQ basis from 2422000.0 in Q4 2025.
Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has 16 years of Income from Continuing Operations data on file, last reported at 4541000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 50.66% year-over-year to 4541000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19048000.0 (down 93.4% YoY) and the FY2025 annual result came in at 17521000.0, down 56.93% from the prior year.
- Income from Continuing Operations eased to 4541000.0 in Q1 2026, from 2422000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 2358000.0 in Q3 2024 to a low of 12553000.0 in Q2 2025.
- A 5-year average of 4009235.29 and a median of 4286000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations sank 353.2% — and 2024, when it surged 169.97%.
- Tracing NUWE's Income from Continuing Operations over 5 years: stood at 1374000.0 in 2022, then tumbled by 353.2% to 6227000.0 in 2023, then soared by 76.43% to 1468000.0 in 2024, then sank by 64.99% to 2422000.0 in 2025, then slumped by 87.49% to 4541000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 4541000.0 (Q1 2026), 2422000.0 (Q4 2025), and 468000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nuwellis | 210,260.00 | -3.71 Mn | 1.50 Mn | -4.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.83 Mn |
| Mar 31, 2026 | -4.54 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | -12.55 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -7.73 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | -6.23 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -4.85 Mn |
| Mar 31, 2023 | -6.49 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -4.47 Mn |
| Dec 31, 2021 | 15.82 Mn |
| Sep 30, 2021 | -5.27 Mn |